Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2015

01-08-2015 | Preclinical study

Role of epithelial–mesenchymal transition markers in triple-negative breast cancer

Authors: Sai Yin Cheung, Yvonne Jia Yu Boey, Valerie Cui Yun Koh, Aye Aye Thike, Jeffrey Chun Tatt Lim, Jabed Iqbal, Puay Hoon Tan

Published in: Breast Cancer Research and Treatment | Issue 3/2015

Login to get access

Abstract

Triple-negative breast cancers (TNBCs) are a heterogeneous group of breast tumours that are often associated with adverse pathological characteristics, poorer clinical outcomes and lack of targeted therapeutic options. Epithelial–mesenchymal transition, which plays a crucial role in tumour development and progression, is characterised by a transition from epithelial to mesenchymal phenotype and loss of proteins involved in maintaining cell junctions. We aimed to correlate protein expression of E-cadherin, Snail2 and transforming growth factor beta (TGF-β) with clinicopathological parameters and survivals of a series of patients with TNBC. The study cohort comprised 767 TNBCs diagnosed at the Department of Pathology, Singapore General Hospital from 1994 to 2012. Immunohistochemistry was performed on sections cut from tissue microarrays using the polymeric method. Staining intensity and percentage of positive tumour cells were evaluated and correlated with clinicopathological findings and clinical outcomes. Loss of E-cadherin expression, Snail2 positivity, cytoplasmic and nuclear expression of TGF-β were observed in 265 (35.2 %), 241 (32.0 %), 272 (36.2 %) and 262 (34.8 %) tumours, respectively. Histological grade significantly correlated with Snail2 positivity (P < 0.001) and loss of membranous E-cadherin expression (P = 0.003). Nuclear expression of TGF-β was inversely correlated with histological grade (P = 0.010). Median follow-up was 73 months, with a maximum of 236 months. Despite a graphical curve for earlier recurrence in patients with tumours harbouring a combinational phenotype of loss of membranous E-cadherin and positive Snail2 expression, there was no statistical significance. Similarly for women with tumours expressing cytoplasmic TGF-β, graphical representation showed poorer metastasis-free survival but without statistical significance. Loss of membranous E-cadherin and positive Snail2 expression are significantly associated with high-grade TNBCs. More work is needed to improve understanding of the role of TGF-β in TNBC.
Literature
1.
go back to reference Bray F, Ren JS, Masuyer E, Ferlay J (2013) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132:1133–1145CrossRefPubMed Bray F, Ren JS, Masuyer E, Ferlay J (2013) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132:1133–1145CrossRefPubMed
2.
go back to reference Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH (2010) Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol 23:123–133CrossRefPubMed Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH (2010) Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol 23:123–133CrossRefPubMed
3.
go back to reference Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70:2247–2258CrossRefPubMed Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70:2247–2258CrossRefPubMed
4.
go back to reference Pal S, Lüchtenborg M, Davies EA, Jack RH (2014) The treatment and survival of patients with triple negative breast cancer in a London population. Springerplus 3:553PubMedCentralCrossRefPubMed Pal S, Lüchtenborg M, Davies EA, Jack RH (2014) The treatment and survival of patients with triple negative breast cancer in a London population. Springerplus 3:553PubMedCentralCrossRefPubMed
5.
go back to reference Reis-Filho JS, Tutt ANJ (2008) Triple negative tumours: a critical review. Histopathology 52:108–118CrossRefPubMed Reis-Filho JS, Tutt ANJ (2008) Triple negative tumours: a critical review. Histopathology 52:108–118CrossRefPubMed
6.
go back to reference Iwase H, Kurebayashi J, Tsuda H, Ohta T, Kurosumi M, Miyamoto K, Yamamoto Y, Iwase T (2010) Clinicopathological analyses of triple negative breast cancer using surveillance data from the registration committee of the japanese breast cancer society. Breast Cancer 17:118–124CrossRefPubMed Iwase H, Kurebayashi J, Tsuda H, Ohta T, Kurosumi M, Miyamoto K, Yamamoto Y, Iwase T (2010) Clinicopathological analyses of triple negative breast cancer using surveillance data from the registration committee of the japanese breast cancer society. Breast Cancer 17:118–124CrossRefPubMed
7.
go back to reference Liu ZB, Wu J, Ping B, Feng LQ, Di GH, Lu JS, Shen KW, Shen ZZ, Shaol ZM (2009) Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype. Tumori 95:53–62PubMed Liu ZB, Wu J, Ping B, Feng LQ, Di GH, Lu JS, Shen KW, Shen ZZ, Shaol ZM (2009) Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype. Tumori 95:53–62PubMed
8.
go back to reference Thiery JP, Acloque H, Huang RYJ, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890CrossRefPubMed Thiery JP, Acloque H, Huang RYJ, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890CrossRefPubMed
9.
go back to reference Larue L, Bellacosa A (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/akt pathways. Oncogene 24:7443–7454CrossRefPubMed Larue L, Bellacosa A (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/akt pathways. Oncogene 24:7443–7454CrossRefPubMed
10.
go back to reference Creighton CJ, Gibbons DL, Kurie JM (2013) The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res 5:187–195PubMedCentralCrossRefPubMed Creighton CJ, Gibbons DL, Kurie JM (2013) The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res 5:187–195PubMedCentralCrossRefPubMed
11.
12.
go back to reference Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, Kawajiri H, Ishikawa T, Wakasa K, Hirakawa K (2010) Significance of e-cadherin expression in triple-negative breast cancer. Br J Cancer 103:249–255PubMedCentralCrossRefPubMed Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, Kawajiri H, Ishikawa T, Wakasa K, Hirakawa K (2010) Significance of e-cadherin expression in triple-negative breast cancer. Br J Cancer 103:249–255PubMedCentralCrossRefPubMed
13.
go back to reference Tang D, Xu S, Zhang Q, Zhao W (2012) The expression and clinical significance of the androgen receptor and e-cadherin in triple-negative breast cancer. Med Oncol 29:526–533CrossRefPubMed Tang D, Xu S, Zhang Q, Zhao W (2012) The expression and clinical significance of the androgen receptor and e-cadherin in triple-negative breast cancer. Med Oncol 29:526–533CrossRefPubMed
14.
go back to reference Savagner P, Yamada KM, Thiery JP (1997) The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 137:1403–1419PubMedCentralCrossRefPubMed Savagner P, Yamada KM, Thiery JP (1997) The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 137:1403–1419PubMedCentralCrossRefPubMed
15.
go back to reference Hajra KM, Chen DYS, Fearon ER (2002) The slug zinc-finger protein represses e-cadherin in breast cancer. Cancer Res 62:1613–1618PubMed Hajra KM, Chen DYS, Fearon ER (2002) The slug zinc-finger protein represses e-cadherin in breast cancer. Cancer Res 62:1613–1618PubMed
16.
go back to reference Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O, Pommier YG, Weinstein JN (2010) Multifactorial regulation of e-cadherin expression: an integrative study. Mol Cancer Ther 9:1–16PubMedCentralCrossRefPubMed Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O, Pommier YG, Weinstein JN (2010) Multifactorial regulation of e-cadherin expression: an integrative study. Mol Cancer Ther 9:1–16PubMedCentralCrossRefPubMed
17.
18.
go back to reference Members of the Guidelines Working Group of the National Coordinating Committee for Breast Pathology (2005) Pathology reporting of breast disease. NHS Cancer Screening Programmes and The Royal College of Pathologists, United Kingdom Members of the Guidelines Working Group of the National Coordinating Committee for Breast Pathology (2005) Pathology reporting of breast disease. NHS Cancer Screening Programmes and The Royal College of Pathologists, United Kingdom
19.
go back to reference Roxanis I (2013) Occurrence and significance of epithelial-mesenchymal transition in breast cancer. J Clin Pathol 66:517–521CrossRefPubMed Roxanis I (2013) Occurrence and significance of epithelial-mesenchymal transition in breast cancer. J Clin Pathol 66:517–521CrossRefPubMed
21.
22.
go back to reference Oon ML, Thike AA, Tan SY, Tan PH (2015) Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat 150:31–41CrossRefPubMed Oon ML, Thike AA, Tan SY, Tan PH (2015) Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat 150:31–41CrossRefPubMed
23.
go back to reference Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ (2014) Tgf-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 106:djt369PubMedCentralCrossRefPubMed Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ (2014) Tgf-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 106:djt369PubMedCentralCrossRefPubMed
24.
go back to reference Muraoka-Cook RS, Dumont N, Arteaga CL (2005) Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. Clin Cancer Res 11:937s–943sPubMed Muraoka-Cook RS, Dumont N, Arteaga CL (2005) Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. Clin Cancer Res 11:937s–943sPubMed
25.
go back to reference Gobbi H, Arteaga CL, Jensen RA, Simpson JF, Dupont WD, Olson SJ, Schuyler PA, Plummer WD, Page DL (2000) Loss of expression of transforming growth factor beta type ii receptor correlates with high tumour grade in human breast in situ and invasive carcinomas. Histopathology 36:168–177CrossRefPubMed Gobbi H, Arteaga CL, Jensen RA, Simpson JF, Dupont WD, Olson SJ, Schuyler PA, Plummer WD, Page DL (2000) Loss of expression of transforming growth factor beta type ii receptor correlates with high tumour grade in human breast in situ and invasive carcinomas. Histopathology 36:168–177CrossRefPubMed
26.
go back to reference Ding X, Park SI, McCauley LK, Wang CY (2013) Signaling between transforming growth factor β (tgf-β) and transcription factor snai2 represses expression of microrna mir-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem 288:10241–10253PubMedCentralCrossRefPubMed Ding X, Park SI, McCauley LK, Wang CY (2013) Signaling between transforming growth factor β (tgf-β) and transcription factor snai2 represses expression of microrna mir-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem 288:10241–10253PubMedCentralCrossRefPubMed
27.
go back to reference Singhai R, Patil VW, Jaiswal SR, Patil SD, Tayade MB, Patil AV (2011) E-cadherin as a diagnostic biomarker in breast cancer. N Am J Med Sci 3:227–233PubMedCentralCrossRefPubMed Singhai R, Patil VW, Jaiswal SR, Patil SD, Tayade MB, Patil AV (2011) E-cadherin as a diagnostic biomarker in breast cancer. N Am J Med Sci 3:227–233PubMedCentralCrossRefPubMed
28.
go back to reference Qureshi HS, Linden MD, Divine G, Raju UB (2006) E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 125:377–385CrossRefPubMed Qureshi HS, Linden MD, Divine G, Raju UB (2006) E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 125:377–385CrossRefPubMed
29.
go back to reference Schwartz AM, Henson DE, Chen D, Rajamarthandan S (2014) Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the seer program. Arch Pathol Lab Med 138:1048–1052CrossRefPubMed Schwartz AM, Henson DE, Chen D, Rajamarthandan S (2014) Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the seer program. Arch Pathol Lab Med 138:1048–1052CrossRefPubMed
30.
go back to reference Moustakas A, Heldin P (2014) Tgfβ and matrix-regulated epithelial to mesenchymal transition. Biochim Biophys Acta 1840:2621–2634CrossRefPubMed Moustakas A, Heldin P (2014) Tgfβ and matrix-regulated epithelial to mesenchymal transition. Biochim Biophys Acta 1840:2621–2634CrossRefPubMed
32.
go back to reference Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15:117–134PubMedCentralCrossRefPubMed Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15:117–134PubMedCentralCrossRefPubMed
33.
go back to reference Aleskandarany MA, Negm OH, Green AR, Ahmed MAH, Nolan CC, Tighe PJ, Ellis IO, Rakha EA (2014) Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study. Breast Cancer Res Treat 145:339–348CrossRefPubMed Aleskandarany MA, Negm OH, Green AR, Ahmed MAH, Nolan CC, Tighe PJ, Ellis IO, Rakha EA (2014) Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study. Breast Cancer Res Treat 145:339–348CrossRefPubMed
Metadata
Title
Role of epithelial–mesenchymal transition markers in triple-negative breast cancer
Authors
Sai Yin Cheung
Yvonne Jia Yu Boey
Valerie Cui Yun Koh
Aye Aye Thike
Jeffrey Chun Tatt Lim
Jabed Iqbal
Puay Hoon Tan
Publication date
01-08-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3485-1

Other articles of this Issue 3/2015

Breast Cancer Research and Treatment 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine